4. Painful diabetic polyneuropathy
Pain Practice · 2024
DOI: 10.1111/papr.13308 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pain Practice, 2024. Verfasst von Xander Zuidema und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Spinal Cord Stimulation, Diabetes Mellitus. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Pain as a symptom of diabetic polyneuropathy (DPN) significantly lowers quality of life, increases mortality and is the main reason for patients with diabetes to seek medical attention. The number of people suffering from painful diabetic polyneuropathy (PDPN) has increased significantly over the past decades.
Methods
The literature on the diagnosis and treatment of diabetic polyneuropathy was retrieved and summarized.
Results
The etiology of PDPN is complex, with primary damage to peripheral nociceptors and altered spinal and supra‐spinal modulation. To achieve better patient outcomes, the mode of diagnosis and treatment of PDPN evolves toward more precise pain‐phenotyping and genotyping based on patient‐specific characteristics, new diagnostic tools, and prior response to pharmacological treatments. According to the Toronto Diabetic Neuropathy Expert Group, a presumptive diagnosis of “probable PDPN” is sufficient to initiate treatment. Proper control of plasma glucose levels, and prevention of risk factors are essential in the treatment of PDPN. Mechanism‐based pharmacological treatment should be initiated as early as possible. If symptomatic pharmacologic treatment fails, spinal cord stimulation (SCS) should be considered. In isolated cases, where symptomatic pharmacologic treatment and SCS are unsuccessful or cannot be used, sympathetic lumbar chain neurolysis and/or radiofrequency ablation (SLCN/SLCRF), dorsal root ganglion stimulation (DRGs) or posterior tibial nerve stimulation (PTNS) may be considered. However, it is recommended that these treatments be applied only in a study setting in a center of expertise.
Conclusions
The diagnosis of PDPN evolves toward pheno‐and genotyping and treatment should be mechanism‐based.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
- Department of Anesthesiology and Pain Management, Diakonessenhuis Utrecht/Zeist, Utrecht, The Netherlands.
- Division of Endocrinology, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
- CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
- Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
- Department of Anesthesiology, Pain Medicine Division, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Sam Eldabe, Jan Van Zundert
Zitieren
APA
Zuidema, X., de Galan, B., Brouwer, B., Cohen, S. P., Eldabe, S., Argoff, C. E., Huygen, F., & Van Zundert, J. (2024). 4. Painful diabetic polyneuropathy. Pain Practice. https://doi.org/10.1111/papr.13308
Vancouver
Zuidema X, de Galan B, Brouwer B, Cohen SP, Eldabe S, Argoff CE, et al. 4. Painful diabetic polyneuropathy. Pain Practice. 2024. doi:10.1111/papr.13308
BibTeX
@article{Zuidema2024,
author = {Zuidema, Xander and de Galan, Bastiaan and Brouwer, Brigitte and Cohen, Steven P and Eldabe, Sam and Argoff, Charles E and Huygen, Frank and Van Zundert, Jan},
title = {4. Painful diabetic polyneuropathy},
journal = {Pain Practice},
year = {2024},
doi = {10.1111/papr.13308}
}
EUVIMED